Camber Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$43.1M Sell
250,000
-100,000
-29% -$16.3M 6.01% 8
2025
Q1
$54.6M Sell
350,000
-450,000
-56% -$64.3M 3.4% 14
2024
Q4
$110M Buy
800,000
+100,000
+14% +$13.1M 4.31% 14
2024
Q3
$105M Buy
+700,000
New +$94.5M 4.06% 11
2024
Q1
Sell
-165,000
Closed -$20.8M 37
2023
Q4
$20.8M Buy
+165,000
New +$16.5M 0.73% 30
2020
Q3
Sell
-350,000
Closed -$51.8M 36
2020
Q2
$51.8M Sell
350,000
-186,710
-35% -$25.6M 2.96% 12
2020
Q1
$60.4M Sell
536,710
-126,290
-19% -$16.4M 3.61% 13
2019
Q4
$92.2M Buy
663,000
+13,000
+2% +$1.44M 4.77% 7
2019
Q3
$62.6M Hold
650,000
3.56% 14
2019
Q2
$74.8M Buy
650,000
+220,000
+51% +$26.3M 4.37% 12
2019
Q1
$50.6M Buy
+430,000
New +$37.7M 2.93% 18

Other funds holding ASND